Searl_2012_Eur.J.Pharmacol_685_38

Reference

Title : Evidence for constitutively-active adenosine receptors at mammalian motor nerve endings - Searl_2012_Eur.J.Pharmacol_685_38
Author(s) : Searl TJ , Silinsky EM
Ref : European Journal of Pharmacology , 685 :38 , 2012
Abstract :

A study was made to determine if constitutively active adenosine receptors are present at mouse motor nerve endings. In preparations blocked by low Ca(2+)/high Mg(2+) solution, 8-cyclopentyl-1,3,dipropylxanthine (CPX, 10-100 nM), which has been reported to be both an A(1) adenosine receptor antagonist and inverse agonist, produced a dose-dependent increase in the number of acetylcholine quanta released by a nerve impulse. Adenosine deaminase, which degrades ambient adenosine into its inactive congener, inosine, failed to alter the response to 100 nM CPX. 8-Cyclopentyltheophylline (CPT, 3 muM), a competitive inhibitor at A(1) adenosine receptors, prevented the increase in acetylcholine release produced by CPX. At normal levels of acetylcholine release, neither adenosine deaminase nor CPX affected acetylcholine release at low frequencies of nerve stimulation in (+)-tubocurarine blocked preparations. The results suggest that a proportion of the acetylcholine release process is controlled by constitutively active adenosine receptors at murine motor nerve endings, providing the first evidence for constitutive activity of G-protein-coupled receptors that modulate the function of mammalian nerve endings.

PubMedSearch : Searl_2012_Eur.J.Pharmacol_685_38
PubMedID: 22542659

Related information

Citations formats

Searl TJ, Silinsky EM (2012)
Evidence for constitutively-active adenosine receptors at mammalian motor nerve endings
European Journal of Pharmacology 685 :38

Searl TJ, Silinsky EM (2012)
European Journal of Pharmacology 685 :38